Carmot Therapeutics IPO

carmot-therapeutics.us

Carmot Therapeutics is focused on the discovery and development of disease-modifying therapies for patients living with metabolic diseases and cancer. Carmot applies Chemotype Evolution (CE), a pioneering drug discovery platform, in combination with unique biological expertise to identify innovative and superior therapeutics.

Founded2008
Total Funding to Date$222.31MM
Register for Details

For more details on financing and valuation for Carmot Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Carmot Therapeutics Ticker Symbol

Carmot Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Carmot Therapeutics Stock Price

The stock price for Carmot Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Carmot Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/26/2022 Series D and D-1 $160.67MM raised $XXX.XX $XXX.XX
9/30/2020 Series C $46.88MM raised $XXX.XX $XXX.XX
1/17/2018 Series B $12.59MM raised $XXX.XX $XXX.XX
4/7/2010 Series A $2.16MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Carmot Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM